Contact Information

  • Additional States: New York
  • Company: John Hosier Healthcare Consulting, LLC
  • Phone: (862) 596-1911
  • Website:
Email this expert

Specialties & Experience

General Specialties:

Marketing and Management

Specialty Focus:

Pharmaceutical Commercialization, Brand Planning, Biotechnology & Pharmaceutical, Managed Markets, Payor, Medicare, Oncology, Hematology, Biosimilars, Specialty Pharmaceuticals, Distribution, Promotion, Pharmaceutical Marketing


B.S. Biology, Baldwin Wallace College

Years in Practice:


Number of Times Deposed/Testified in Last 4 Yrs:


Additional Information

Mr. Hosier is a strategic advisor to the life sciences industry drawing on more then 25 years of sales, marketing and managed markets experience in commercial healthcare organizations. He has provided insights to small molecule & biotechnology companies across multiple therapeutic areas but has maintained a heavy concentration in oncology and specialty pharmaceuticals. He has led brand launch; corporate, franchise, and strategic brand planning; commercial integration; organizational design; and operational effectiveness from multiple perspectives (as the client, as the independent consultant, and as an agency lead). Mr. Hosier’s firm has architected the launch of rare disease and oncology business units for multiple pharmaceutical clients (large and small); led development of the managed markets, trade, and distribution strategy for the launch of new chemical entities (NCEs) and 505(b)2 assets for various organizations; and provided commercial assessment and recommendation of various licensing and co-promote deals between organizations. Mr. Hosier is an active mentor with various biotech/healthtech accelerators in the tri-state area; serves as council member and advisor to numerous market research firms serving the financial industry; is an adjunct professor of pharmaceutical marketing with the Silberman School of Business, FDU; and has served as an expert witness since 2015. Before launching his own consulting firm, Mr. Hosier held leadership positions of increasing responsibility including strategy, sales, marketing, account management, state & federal policy, pricing/contracting, and commercial operations. He has managed $80M-$2B P&Ls. His roles have spanned across 11 therapeutic areas (including orphan and ultra-orphan disease states) and nearly 50 marketed products (oral solid and injectable/IV formulations, device and diagnostics) with various pharmaceutical and biotech organizations including: Zeneca, Pharmacia & Upjohn, Pfizer, Roche, Eisai.